000148331 001__ 148331
000148331 005__ 20240229123031.0
000148331 0247_ $$2doi$$a10.1002/ijc.32415
000148331 0247_ $$2pmid$$apmid:31107546
000148331 0247_ $$2ISSN$$a0020-7136
000148331 0247_ $$2ISSN$$a1097-0215
000148331 0247_ $$2altmetric$$aaltmetric:60752705
000148331 037__ $$aDKFZ-2019-02887
000148331 041__ $$aeng
000148331 082__ $$a610
000148331 1001_ $$00000-0003-4646-3513$$aObón-Santacana, Mireia$$b0
000148331 245__ $$aConsumption of nuts and seeds and pancreatic ductal adenocarcinoma risk in the European Prospective Investigation into Cancer and Nutrition.
000148331 260__ $$aBognor Regis$$bWiley-Liss$$c2020
000148331 3367_ $$2DRIVER$$aarticle
000148331 3367_ $$2DataCite$$aOutput Types/Journal article
000148331 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1575881283_16294
000148331 3367_ $$2BibTeX$$aARTICLE
000148331 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000148331 3367_ $$00$$2EndNote$$aJournal Article
000148331 520__ $$aFour epidemiologic studies have assessed the association between nut intake and pancreatic cancer risk with contradictory results. The present study aims to investigate the relation between nut intake (including seeds) and pancreatic ductal adenocarcinoma (PDAC) risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Cox proportional hazards models were used to estimate hazards ratio (HR) and 95% confidence intervals (95% CI) for nut intake and PDAC risk. Information on intake of nuts was obtained from the EPIC country-specific dietary questionnaires. After a mean follow-up of 14 years, 476,160 participants were eligible for the present study and included 1,283 PDAC cases. No association was observed between consumption of nuts and PDAC risk (highest intake vs nonconsumers: HR, 0.89; 95% CI, 0.72-1.10; p-trend = 0.70). Furthermore, no evidence for effect-measure modification was observed when different subgroups were analyzed. Overall, in EPIC, the highest intake of nuts was not statistically significantly associated with PDAC risk.
000148331 536__ $$0G:(DE-HGF)POF3-313$$a313 - Cancer risk factors and prevention (POF3-313)$$cPOF3-313$$fPOF III$$x0
000148331 588__ $$aDataset connected to CrossRef, PubMed,
000148331 7001_ $$aLuján-Barroso, Leila$$b1
000148331 7001_ $$aFreisling, Heinz$$b2
000148331 7001_ $$aNaudin, Sabine$$b3
000148331 7001_ $$00000-0002-5956-5693$$aBoutron-Ruault, Marie-Christine$$b4
000148331 7001_ $$00000-0003-2297-3869$$aMancini, Francesca Romana$$b5
000148331 7001_ $$aRebours, Vinciane$$b6
000148331 7001_ $$0P:(DE-He78)0907a10ba1dc8f53f04907f54f6fdcfe$$aKühn, Tilman$$b7$$udkfz
000148331 7001_ $$0P:(DE-He78)fb68a9386399d72d84f7f34cfc6048b4$$aKatzke, Verena$$b8$$udkfz
000148331 7001_ $$aBoeing, Heiner$$b9
000148331 7001_ $$aTjønneland, Anne$$b10
000148331 7001_ $$aOlsen, Anja$$b11
000148331 7001_ $$aOvervad, Kim$$b12
000148331 7001_ $$aLasheras, Cristina$$b13
000148331 7001_ $$aRodríguez-Barranco, Miguel$$b14
000148331 7001_ $$aAmiano, Pilar$$b15
000148331 7001_ $$aSantiuste, Carmen$$b16
000148331 7001_ $$aArdanaz, Eva$$b17
000148331 7001_ $$aKhaw, Kay-Thee$$b18
000148331 7001_ $$aWareham, Nicholas J$$b19
000148331 7001_ $$00000-0002-7733-8750$$aSchmidt, Julie A$$b20
000148331 7001_ $$aAune, Dagfinn$$b21
000148331 7001_ $$aTrichopoulou, Antonia$$b22
000148331 7001_ $$aThriskos, Paschalis$$b23
000148331 7001_ $$aPeppa, Eleni$$b24
000148331 7001_ $$aMasala, Giovanna$$b25
000148331 7001_ $$aGrioni, Sara$$b26
000148331 7001_ $$aTumino, Rosario$$b27
000148331 7001_ $$aPanico, Salvatore$$b28
000148331 7001_ $$aBueno-de-Mesquita, Bas$$b29
000148331 7001_ $$aSciannameo, Veronica$$b30
000148331 7001_ $$aVermeulen, Roel$$b31
000148331 7001_ $$aSonestedt, Emily$$b32
000148331 7001_ $$aSund, Malin$$b33
000148331 7001_ $$aWeiderpass, Elisabete$$b34
000148331 7001_ $$aSkeie, Guri$$b35
000148331 7001_ $$aGonzález, Carlos A$$b36
000148331 7001_ $$aRiboli, Elio$$b37
000148331 7001_ $$00000-0001-5256-0163$$aDuell, Eric J$$b38
000148331 773__ $$0PERI:(DE-600)1474822-8$$a10.1002/ijc.32415$$gVol. 146, no. 1, p. 76 - 84$$n1$$p76 - 84$$tInternational journal of cancer$$v146$$x1097-0215$$y2020
000148331 909CO $$ooai:inrepo02.dkfz.de:148331$$pVDB
000148331 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)0907a10ba1dc8f53f04907f54f6fdcfe$$aDeutsches Krebsforschungszentrum$$b7$$kDKFZ
000148331 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)fb68a9386399d72d84f7f34cfc6048b4$$aDeutsches Krebsforschungszentrum$$b8$$kDKFZ
000148331 9131_ $$0G:(DE-HGF)POF3-313$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vCancer risk factors and prevention$$x0
000148331 9141_ $$y2020
000148331 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz
000148331 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000148331 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000148331 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000148331 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bINT J CANCER : 2017
000148331 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List
000148331 915__ $$0StatID:(DE-HGF)0110$$2StatID$$aWoS$$bScience Citation Index
000148331 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000148331 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000148331 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences
000148331 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews
000148331 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bINT J CANCER : 2017
000148331 9201_ $$0I:(DE-He78)C020-20160331$$kC020$$lEpidemiologie von Krebserkrankungen$$x0
000148331 980__ $$ajournal
000148331 980__ $$aVDB
000148331 980__ $$aI:(DE-He78)C020-20160331
000148331 980__ $$aUNRESTRICTED